Profile
James R.
Carr is currently the Chief Clinical Development Officer at Stealth BioTherapeutics Corp.
He previously worked as the Vice President-Marketing at Anesiva, Inc. and ARCA biopharma, Inc. from 2008 to 2010.
He also served as a Regional Medical Scientist at GlaxoSmithKline, Inc. Dr. Carr obtained his undergraduate and doctorate degrees from the University of Minnesota in 1989 and 1990 respectively.
James R. Carr active positions
| Companies | Position | Start |
|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Chief Tech/Sci/R&D Officer | 16/03/2014 |
Former positions of James R. Carr
| Companies | Position | End |
|---|---|---|
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Sales & Marketing | 31/10/2010 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
Anesiva, Inc.
Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain management | Sales & Marketing | - |
Education of James R. Carr
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Anesiva, Inc.
Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain management | Health Technology |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stealth BioTherapeutics Corp.
Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops investigational drugs for the treatment of diseases involving mitochondrial dysfunction | Health Technology |
- Stock Market
- Insiders
- James R. Carr
















